Follow
Rouxjeane Venter
Rouxjeane Venter
DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research | SAMRC Centre for Tuberculosis
Verified email at sun.ac.za - Homepage
Title
Cited by
Cited by
Year
Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results?
G Theron, R Venter, G Calligaro, L Smith, J Limberis, R Meldau, ...
Clinical Infectious Diseases 62 (8), 995-1001, 2016
1632016
False positive Xpert MTB/RIF results in re-tested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes
G Theron, R Venter, L Smith, A Esmail, P Randall, V Sood, S Oelfese, ...
Journal of Clinical Microbiology, JCM.01696-17, 2018
1072018
Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis
G Theron, J Limberis, R Venter, L Smith, E Pietersen, A Esmail, ...
Nature medicine 26 (9), 1435-1443, 2020
362020
Investigating non-sterilizing cure in TB patients at the end of successful anti-TB therapy
CGG Beltran, T Heunis, J Gallant, R Venter, N Du Plessis, AG Loxton, ...
Frontiers in cellular and infection microbiology 10, 443, 2020
252020
Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?
KV Driessche, PZ Mahlobo, R Venter, J Caldwell, K Jennings, AH Diacon, ...
The Lancet Respiratory Medicine 9 (4), 340-342, 2021
242021
Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate secondline genotypic drug susceptibility testing and spoligotyping
R Venter, B Derendinger, M de Vos, S Pillay, T Dolby, J Simpson, ...
Scientific Reports 7 (1), 14854, 2017
142017
Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross …
R Venter, S Minnies, B Derendinger, H Tshivhula, M De Vos, T Dolby, ...
Scientific Reports 10 (1), 2633, 2020
62020
Direct genotyping of Mycobacterium tuberculosis from Xpert® MTB/RIF remnants
ET Mambuque, E Abascal, R Venter, H Bulo, E Bouza, G Theron, ...
Tuberculosis 111, 202-206, 2018
62018
Culture filtrate supplementation can be used to improve Mycobacterium tuberculosis culture positivity for spinal tuberculosis diagnosis
CGG Beltran, R Venter, TN Mann, JH Davis, BD Kana, G Walzl
Frontiers in Cellular and Infection Microbiology 12, 1065893, 2022
32022
Frequent suboptimal thermocycler ramp rate usage negatively impacts GenoType MTBDRsl VER 2.0 performance for second-line drug-resistant tuberculosis diagnosis
B Derendinger, M de Vos, S Pillay, R Venter, J Metcalfe, Y Ghebrekristos, ...
The Journal of Molecular Diagnostics 24 (5), 494-502, 2022
32022
Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation
YT Ghebrekristos, N Beylis, CM Centner, R Venter, B Derendinger, ...
The Lancet Microbe 4 (10), e822-e829, 2023
12023
Frequency and clinical profile of false positive Xpert MTB/RIF results in patients previously treated for tuberculosis
G Theron, R Venter, L Smith, GL Calligaro, A Esmail, RM Warren, ...
A26. DIAGNOSIS AND TREATMENT OF TUBERCULOSIS, A1171-A1171, 2017
12017
Something from nothing: Sensitivity and specificity of Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection
YT Ghebrekristos, N Beylis, CM Centner, R Venter, B Derendinger, ...
medRxiv, 2022.12. 07.22283223, 2022
2022
Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?(vol 9, pg 340, 2021)
K Vanden Driessche, PZ Mahlobo, R Venter
Lancet Respiratory Medicine, E114-E114, 2021
2021
Novel approaches for the diagnosis of drug-resistance, treatment response, and infectiousness in patients with tuberculosis (the eDIToR study–Diagnosis Infectiousness and …
R Venter
Stellenbosch: Stellenbosch University, 2020
2020
Bacterial And Host Determinants Of Infectiousness In Patients With Drug-Susceptible Or Drug-Resistant Tuberculosis
G Theron, L Smith, JD Limberis, R Venter, A Esmail, R McNerney, ...
D96. INFECTIOUSNESS AND TRANSMISSION OF TUBERCULOSIS, A7319-A7319, 2017
2017
A26 DIAGNOSIS AND TREATMENT OF TUBERCULOSIS: Frequency And Clinical Profile Of False Positive Xpert Mtb/rif Results In Patients Previously Treated For Tuberculosis
G Theron, R Venter, L Smith, GL Calligaro, A Esmail, RM Warren, ...
American Journal of Respiratory and Critical Care Medicine 195, 2017
2017
D96 INFECTIOUSNESS AND TRANSMISSION OF TUBERCULOSIS: Bacterial And Host Determinants Of Infectiousness In Patients With Drug-Susceptible Or Drug-Resistant Tuberculosis
G Theron, L Smith, JD Limberis, R Venter, A Esmail, R McNerney, ...
American Journal of Respiratory and Critical Care Medicine 195, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–18